Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Treatment source : Ocutx.gcs-web.com save search
Ocular Therapeutix™ Completes Enrollment of the HELIOS Clinical Trial of OTX-TKI for the Treatment of Diabetic Retinopathy
Published: 2023-06-07 (Crawled : 12:00) - ocutx.gcs-web.com
OCUL | News | $5.07 -13.48% 2.6M
|
Health Technology
|
| O: 0.39%
H: 0.91%
C: -3.39%
ocular treatment trial diabetic
Ocular Therapeutix™ Announces Interim 7-month Data from U.S. Phase 1 Clinical Trial of OTX-TKI for the Treatment of Wet AMD
Published: 2022-09-27 (Crawled : 10:00) - ocutx.gcs-web.com
OCUL | News | $5.07 -13.48% 2.6M
|
Health Technology
|
| O: -4.36%
H: 5.15%
C: -14.65%
treatment ocular trial phase 1
Ocular Therapeutix™ Announces Topline Results for Phase 2 Clinical Trial of OTX-DED for the Short-Term Treatment of Dry Eye Disease
Published: 2021-12-06 (Crawled : 12:00) - ocutx.gcs-web.com
OCUL | News | $5.07 -13.48% 2.6M
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
dry eye treatment phase 2 eye ocular eye disease trial disease topline results results topline
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
ZCMD | $1.86 28.28% 29M
|
Commercial Services
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.3022 24.82% 51M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.